Abstract
Rheumatoid arthritis (RA), an inflammatory joint disorder, independently increases the risk of cardiovascular disease (CVD). IL-1β contributes to both RA and CVD. We hypothesised that inhibiting IL-1 signalling with the IL-1R antagonist, anakinra, would dampen inflammation and promote resolution of atherosclerosis in arthritic mice. Low-density lipoprotein receptor (Ldlr)-deficient mice were fed a Western-type diet for 14 weeks to develop atherosclerotic plaques. Mice were then switched to a chow diet, promoting lesion regression, and randomised to a control group or into groups where arthritis was induced by passive transfer of K/BxN arthritogenic serum. The arthritic mice were further randomised to vehicle or anakinra. Arthritis impaired atherosclerotic lesion regression when cholesterol was lowered. This was associated with a higher burden of plaque macrophages, likely due to monocytosis, driven by myelopoiesis in the bone marrow and spleen. Interestingly, delayed intervention with anakinra had no effect on arthritis in these mice. However, a significant improvement in atherosclerotic plaque remodelling to a more stable phenotype was observed. This was associated with fewer circulating monocytes, caused by a reduction in spl...Continue Reading
References
Aug 1, 1983·Arthritis and Rheumatism·D D WoodP L Cohen
Jan 19, 2000·The Journal of Experimental Medicine·R HoraiY Iwakura
May 19, 2000·Arthritis and Rheumatism·Y JiangD McCabe
May 18, 2001·Seminars in Arthritis and Rheumatism·W P Arend
Mar 29, 2002·Arthritis and Rheumatism·Stanley CohenDorothy McCabe
Jul 3, 2002·The Journal of Experimental Medicine·Hong JiChristophe Benoist
Apr 15, 2004·Annals of the Rheumatic Diseases·S B CohenUNKNOWN 990145 Study Group
Jan 4, 2007·The Journal of Clinical Investigation·Frank TackeGwendalyn J Randolph
Jan 4, 2007·The Journal of Clinical Investigation·Filip K SwirskiMikael J Pittet
May 14, 2008·Circulation·Ignatios IkonomidisDimitrios T Kremastinos
Apr 30, 2010·Nature·Peter DuewellEicke Latz
Jul 27, 2010·Archives of Cardiovascular Diseases·Christophe MeuneYannick Allanore
Aug 5, 2010·Molecular Medicine·Gianfranco FerraccioliFabrizio De Benedetti
Oct 5, 2011·The Journal of Clinical Investigation·Andrew J MurphyAlan R Tall
Apr 16, 2013·Nature Medicine·Andrew J MurphyNan Wang
May 15, 2013·Cell Metabolism·Prabhakara R NagareddyIra J Goldberg
Dec 18, 2013·Immunity·Cecilia GarlandaAlberto Mantovani
Feb 8, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew J MurphyLaurent Yvan-Charvet
May 2, 2014·Circulation. Cardiovascular Imaging·Ignatios IkonomidisJohn Lekakis
May 9, 2014·Cell Metabolism·Prabhakara R NagareddyAndrew J Murphy
Apr 1, 2015·Nature Reviews. Rheumatology·Sarah Skeoch, Ian N Bruce
Feb 13, 2016·European Heart Journal·Andrew J Murphy, Alan R Tall
Apr 26, 2016·Nature Cell Biology·Eric M PietrasEmmanuelle Passegué
Jun 29, 2016·Clinical & Translational Immunology·Michael J KraakmanAndrew J Murphy
Mar 17, 2017·Nature Reviews. Cardiology·Mohammed Shamim RahmanKevin J Woollard
Mar 30, 2017·Cell Reports·Alyssa CareyAnupriya Agarwal
May 16, 2017·The Journal of Clinical Investigation·Michael J KraakmanAndrew J Murphy
Aug 29, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN CANTOS Trial Group
Jun 16, 2018·European Heart Journal·Dragana DragoljevicAndrew J Murphy
Jan 17, 2020·Circulation·Gopalkrishna SreejitPrabhakara R Nagareddy